Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 2
Submit an article Journal homepage
184
Views
52
CrossRef citations to date
0
Altmetric
Reviews

Oncolytic measles virus strains in the treatment of gliomas

Cory Allen Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Georgia Paraskevakou Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD,
Chunsheng Liu Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD,
Ianko D Iankov Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
, MD PhD,
Pavlos Msaouel Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Paula Zollman Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Rae Myers Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Kah Whye Peng Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
,
Stephen J Russell Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]
&
Evanthia Galanis Mayo Clinic, Molecular Medicine Department, 200 First Street SW, Rochester, MN 55905, USA +1 507 284 2511; +1 507 284 1803; [email protected]; Mayo Clinic, Division of Medical Oncology, 200 First Street SW, Rochester, MN 55905, USA
, MD show all
Pages 213-220 | Published online: 14 Jan 2008

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Steven Robinson & Evanthia Galanis. (2017) Potential and clinical translation of oncolytic measles viruses. Expert Opinion on Biological Therapy 17:3, pages 353-363.
Read now
Brian Hutzen, Corey Raffel & Adam W Studebaker. (2015) Advances in the design and development of oncolytic measles viruses. Oncolytic Virotherapy 4, pages 109-118.
Read now
David E Piccioni & Santosh Kesari. (2013) Clinical trials of viral therapy for malignant gliomas. Expert Review of Anticancer Therapy 13:11, pages 1297-1305.
Read now
Pavlos Msaouel, Mateusz Opyrchal, Evidio Domingo Musibay & Evanthia Galanis. (2013) Oncolytic measles virus strains as novel anticancer agents. Expert Opinion on Biological Therapy 13:4, pages 483-502.
Read now

Articles from other publishers (48)

Zumama Khalid, Simona Coco, Nadir Ullah, Alessandra Pulliero, Katia Cortese, Serena Varesano, Andrea Orsi & Alberto Izzotti. (2023) Anticancer Activity of Measles–Mumps–Rubella MMR Vaccine Viruses against Glioblastoma. Cancers 15:17, pages 4304.
Crossref
Kenneth Lundstrom. (2022) Self-replicating vehicles based on negative strand RNA viruses. Cancer Gene Therapy 30:6, pages 771-784.
Crossref
P. O. Vorobyev, F. E. Babaeva, A. V. Panova, J. Shakiba, S. K. Kravchenko, A. V. Soboleva & A. V. Lipatova. (2022) Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases. Molecular Biology 56:5, pages 684-695.
Crossref
Kimberly B. Viker, Michael B. Steele, Ianko D. Iankov, Susanna C. Concilio, Arun Ammayappan, Brad Bolon, Nathan J. Jenks, Matthew P. Goetz, Eleni Panagioti, Mark J. Federspiel, Minetta C. Liu, Kah Whye Peng & Evanthia Galanis. (2022) Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene. Molecular Therapy - Methods & Clinical Development 26, pages 532-546.
Crossref
Dileep D. Monie, Archis R. BhandarkarIan F. ParneyCristina CorreiaJann N. Sarkaria, Richard G. VileHu Li. (2021) Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma. Neurosurgical Focus 50:2, pages E10.
Crossref
O. I. Kit, S. N. Ignatov, E. Yu. Zlatnik, N. V. Soldatkina, E. E. Rostorguev, A. B. Sagakyants, E. S. Bondarenko & A. O. Sitkovskaya. (2020) ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW). Siberian journal of oncology 19:6, pages 133-140.
Crossref
Mohsen Keshavarz, Ailar Sabbaghi, Seyed Mohammad Miri, Abolhasan Rezaeyan, Yaser Arjeini & Amir Ghaemi. (2020) Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?. Cancer Cell International 20:1.
Crossref
Megan L Montoya, Noriyuki Kasahara & Hideho Okada. (2020) Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. Neuro-Oncology Practice 7:5, pages 465-476.
Crossref
Ceera Manikandan, Akshita Kaushik & Dwaipayan Sen. (2019) Viral vector: potential therapeutic for glioblastoma multiforme. Cancer Gene Therapy 27:5, pages 270-279.
Crossref
Chase Burton & Eric Bartee. (2019) Syncytia Formation in Oncolytic Virotherapy. Molecular Therapy - Oncolytics 15, pages 131-139.
Crossref
Joshua Loya, Charlie Zhang, Emily Cox, Achal S Achrol & Santosh Kesari. (2019) Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. CNS Oncology 8:3, pages CNS40.
Crossref
Puja Sharma & Waldemar Debinski. (2018) Receptor-Targeted Glial Brain Tumor Therapies. International Journal of Molecular Sciences 19:11, pages 3326.
Crossref
Xue Zhang, Guochao Mao & Anthony N. van den Pol. (2018) Chikungunya-vesicular stomatitis chimeric virus targets and eliminates brain tumors. Virology 522, pages 244-259.
Crossref
Praveen K. Bommareddy, Megha Shettigar & Howard L. Kaufman. (2018) Integrating oncolytic viruses in combination cancer immunotherapy. Nature Reviews Immunology 18:8, pages 498-513.
Crossref
Julius W. Kim, Katarzyna C. Pituch, Annie Xiao, Jacob S. Young, Wojciech K. Panek, Megan E. Muroski, Aida Rashidi, J. Robert Kane, Deepak Kanojia & Maciej S. Lesniak. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 211 227 .
Naiara Martínez-Vélez, Candelaria Gomez-Manzano, Juan Fueyo, Ana Patiño-García & Marta M. Alonso. 2018. Gene Therapy in Neurological Disorders. Gene Therapy in Neurological Disorders 357 384 .
Joon H. Uhm & Alyx B. Porter. (2017) Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era. Mayo Clinic Proceedings 92:6, pages 995-1004.
Crossref
Anastasie M. Dunn‐Pirio & Gordana Vlahovic. (2016) Immunotherapy approaches in the treatment of malignant brain tumors. Cancer 123:5, pages 734-750.
Crossref
J.W. Kim, J. Murphy, A.L. Chang, D.A. Spencer, J.R. Kane, D. Kanojia, A. Rashidi, J.S. Young & M.S. Lesniak. 2017. Mesenchymal Stromal Cells as Tumor Stromal Modulators. Mesenchymal Stromal Cells as Tumor Stromal Modulators 475 499 .
Sangeet Lal, Kah-Whye Peng, Michael B. Steele, Nathan Jenks, Hong Ma, Gary Kohanbash, Joanna J. Phillips & Corey Raffel. (2016) Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice. Human Gene Therapy Clinical Development 27:4, pages 145-151.
Crossref
Rui Wang, Bo Wei, Jun Wei, Zhaohui Li, Yu Tian & Chao Du. (2016) Caspase-related apoptosis genes in gliomas by RNA-seq and bioinformatics analysis. Journal of Clinical Neuroscience 33, pages 259-263.
Crossref
Adam W. Studebaker, Brian Hutzen, Christopher R. Pierson, Terri A. Shaffer, Corey Raffel & Eric M. Jackson. (2015) Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Neuro-Oncology 17:12, pages 1568-1577.
Crossref
Tej D. Azad, James Pan, Ian D. Connolly, Austin Remington, Christy M. Wilson & Gerald A. Grant. (2015) Therapeutic strategies to improve drug delivery across the blood-brain barrier. Neurosurgical Focus 38:3, pages E9.
Crossref
Carlos Kamiya-Matsuoka & Mark R Gilbert. (2015) Treating recurrent glioblastoma: an update. CNS Oncology 4:2, pages 91-104.
Crossref
E Domingo-Musibay, C Allen, C Kurokawa, J J Hardcastle, I Aderca, P Msaouel, A Bansal, H Jiang, T R DeGrado & E Galanis. (2014) Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma. Cancer Gene Therapy 21:11, pages 483-490.
Crossref
Anna CastletonAditi DeyBrendan BeatonBella PatelAnne Aucher, Daniel M. Davis & Adele K. Fielding. (2014) Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity. Blood 123:9, pages 1327-1335.
Crossref
M Opyrchal, C Allen, P Msaouel, I Iankov & E Galanis. (2013) Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy. Cancer Gene Therapy 20:11, pages 630-637.
Crossref
Aneta Kwiatkowska, Mohan Nandhu, Prajna Behera, E. Chiocca & Mariano Viapiano. (2013) Strategies in Gene Therapy for Glioblastoma. Cancers 5:4, pages 1271-1305.
Crossref
C Allen, M Opyrchal, I Aderca, M A Schroeder, J N Sarkaria, E Domingo, M J Federspiel & E Galanis. (2012) Oncolytic measles virus strains have significant antitumor activity against glioma stem cells. Gene Therapy 20:4, pages 444-449.
Crossref
Andrea M. Murphy & Samuel D. Rabkin. (2013) Current status of gene therapy for brain tumors. Translational Research 161:4, pages 339-354.
Crossref
T Sugiyama, M Yoneda, T Kuraishi, S Hattori, Y Inoue, H Sato & C Kai. (2012) Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. Gene Therapy 20:3, pages 338-347.
Crossref
Vahid Salimi, Masoumeh Tavakoli Yaraki, Mahmood Mahmoodi, Shahram Shahabi, Mohammad Javad Gharagozlou, Fazel Shokri & Talat Mokhtari Azad. (2013) The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431. Iranian Red Crescent Medical Journal 15:1, pages 62-7.
Crossref
Nicholas S .R. Sauderson, Maria G. Castro & Pedro R. Lowenstein. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics 1 32 .
Mateusz OpyrchalCory AllenIanko IankovIleana AdercaMark SchroederJann SarkariaEvanthia Galanis. (2012) Effective Radiovirotherapy for Malignant Gliomas by Using Oncolytic Measles Virus Strains Encoding the Sodium Iodide Symporter (MV-NIS). Human Gene Therapy 23:4, pages 419-427.
Crossref
Yann Touchefeu, Ulrike Schick & Kevin J. Harrington. (2012) Le virus de la rougeole. médecine/sciences 28:4, pages 388-394.
Crossref
Guido Wollmann, Koray Ozduman & Anthony N. van den Pol. (2012) Oncolytic Virus Therapy for Glioblastoma Multiforme. The Cancer Journal 18:1, pages 69-81.
Crossref
Mathias F Leber, Sascha Bossow, Vincent HJ Leonard, Karim Zaoui, Christian Grossardt, Marie Frenzke, Tanner Miest, Stefanie Sawall, Roberto Cattaneo, Christof von Kalle & Guy Ungerechts. (2011) MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism. Molecular Therapy 19:6, pages 1097-1106.
Crossref
Bella Patel, Aditi Dey, Ehsan Ghorani, Shaji Kumar, Yogeshkumar Malam, Lena Rai, Andrew J Steele, Jennifer Thomson, R Gitendra Wickremasinghe, Yu Zhang, Anna Z Castleton & Adele K Fielding. (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. Molecular Therapy 19:6, pages 1034-1040.
Crossref
E Galanis. (2010) Therapeutic Potential of Oncolytic Measles Virus: Promises and Challenges. Clinical Pharmacology & Therapeutics 88:5, pages 620-625.
Crossref
Leopold Arko, Igor Katsyv, Grace E. Park, William Patrick Luan & John K. Park. (2010) Experimental approaches for the treatment of malignant gliomas. Pharmacology & Therapeutics 128:1, pages 1-36.
Crossref
H Li, K-W Peng, D Dingli, R A Kratzke & S J Russell. (2010) Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Therapy 17:8, pages 550-558.
Crossref
Karsten Geletneky, Andreas D. Hartkopf, Robert Krempien, Jean Rommelaere & Joerg R. Schlehofer. (2010) Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection. Journal of Biomedicine and Biotechnology 2010, pages 1-9.
Crossref
Anthony N. van den Pol, Koray Ozduman, Guido Wollmann, Winson S.C. Ho, Ian Simon, Yang Yao, John K. Rose & Prabhat Ghosh. (2009) Viral strategies for studying the brain, including a replication‐restricted self‐amplifying delta‐G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi‐like expression. Journal of Comparative Neurology 516:6, pages 456-481.
Crossref
Monique H. Verheije, Martine L. M. Lamfers, Thomas Würdinger, Guy C. M. Grinwis, Winald R. Gerritsen, Victor W. van Beusechem & Peter J. M. Rottier. (2009) Coronavirus Genetically Redirected to the Epidermal Growth Factor Receptor Exhibits Effective Antitumor Activity against a Malignant Glioblastoma. Journal of Virology 83:15, pages 7507-7516.
Crossref
Kaveh Asadi-Moghaddam & E. Antonio Chiocca. (2009) Gene- and viral-based therapies for brain tumors. Neurotherapeutics 6:3, pages 547-557.
Crossref
S. J. Russell & K. W. Peng. 2009. Measles. Measles 213 241 .
Pavlos Msaouel, Ianko D. Iankov, Cory Allen, John C. Morris, Veronika von Messling, Roberto Cattaneo, Michael Koutsilieris, Stephen J. Russell & Evanthia Galanis. (2008) Engineered measles virus as a novel oncolytic therapy against prostate cancer. The Prostate 69:1, pages 82-91.
Crossref
Rae MyersMary HarveyTimothy J. KaufmannSuzanne M. GreinerJames W. KrempskiCorey RaffelSteven E. SheltonDiane SoeffkerPaula ZollmanMark J. FederspielMichael BlancoEvanthia Galanis. (2008) Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas. Human Gene Therapy 19:7, pages 690-698.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.